We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Death-associated protein kinase 1 variation and Parkinson's disease.
- Authors
Dachsel, J. C.; Wider, C.; Vilariño-Güell, C.; Aasly, J. O.; Rajput, A.; Rajput, A. H.; Lynch, T.; Craig, D.; Krygowska-Wajs, A.; Jasinska-Myga, B.; Opala, G.; Barcikowska, M.; Czyzewski, K.; Wu, R. -M.; Heckman, M. G.; Uitti, R. J.; Wszolek, Z. K.; Farrer, M. J.; Ross, O. A.
- Abstract
Background and purpose: Mutations of the LRRK2 gene are now recognized as major risk factors for Parkinson's disease. The Lrrk2 protein is a member of the ROCO family, which also includes Lrrk1 and Dapk1. Functional genetic variants of the DAPK1 gene (rs4877365 and rs4878104) have been previously associated with Alzheimer's disease. Methods: Herein, we assessed the role of DAPK1 variants (rs4877365 and rs4878104) in risk of Parkinson's disease with Sequenom iPLEX genotyping, employing one Taiwanese series (391 patients with Parkinson's disease, 344 controls) and five separate Caucasian series' (combined sample size 1962 Parkinson's disease patients, 1900 controls). Results: We observed no evidence of association for rs4877365 and rs4878104 and risk of Parkinson's disease in any of the individual series or in the combined Caucasian series under either an additive or recessive model. Conclusion: These specific DAPK1 intronic variants do not increase the risk of Parkinson's disease. However, further functional studies are required to elucidate the potential therapeutic implications with the dimerization of the Dapk1 and Lrrk2 proteins.
- Subjects
GENETIC mutation; DISEASE risk factors; PARKINSON'S disease; PROTEIN kinases; BRAIN diseases; TAIWANESE people
- Publication
European Journal of Neurology, 2011, Vol 18, Issue 8, p1090
- ISSN
1351-5101
- Publication type
Article
- DOI
10.1111/j.1468-1331.2010.03255.x